Arcturus Therapeutics has entered into an agreement with Vinbiocare Biotechnology to establish a new plant in Vietnam to produce Arcturus' investigational coronavirus vaccines. As part of the agreement, Vinbiocare will build the production site and Arcturus will provide it with access to proprietary technologies and processes for the production of investigational vaccines. The planned capacity of the plant is 200 million doses of vaccines per year.